Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
about
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada.Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancerPersonalized genomic disease risk of volunteers.Wnt antagonist gene polymorphisms and renal cancer.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.The genetic epidemiology of prostate cancer and its clinical implications.Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.LRP2, an auxiliary receptor that controls sonic hedgehog signaling in development and disease.Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates.Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Genetic variants associated with predisposition to prostate cancer and potential clinical implications.Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival.Significant Association Between Polymorphisms of Wnt Antagonist Genes and Lung Cancer.
P2860
Q30504100-ECF26C1A-D497-4027-ABEC-0E6A808BC62AQ34795962-002E2BE5-C540-4701-A943-A4EB7338E0DEQ36674846-13D8B539-6316-48CE-830D-9ED977D0A082Q37240475-10BC4DE6-4ABB-4DF1-BC62-665D8A92CB1FQ37613592-CBA617EA-83F7-43FE-9D62-ED95B1266255Q37972706-8C0DD41D-234A-41B9-9B10-31B216FBDB01Q38168060-B2CFA051-88F9-4DA4-8A08-1C8E9BF4C2FFQ38242231-6DB1D11D-0617-4D11-8C82-C0E14C004186Q38731576-D922D535-1358-4847-B5A3-9B71F0A30AA7Q38920389-55C6EED4-4B08-454A-8EEE-A84627F52FDBQ39141778-EF36DBA8-FC20-49A6-BDE7-16A62BB2D7F1Q43415543-337BAE4B-813D-4E4E-8645-A81492E9F416Q45347511-DC77EA31-3D36-4609-93F0-7536EBB8DF1AQ53212479-79A6F980-B6A4-4D19-8F03-E0673014E4E7
P2860
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@ast
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@en
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@nl
type
label
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@ast
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@en
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@nl
prefLabel
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@ast
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@en
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@nl
P2093
P2860
P1476
Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
@en
P2093
Danielle M Karyadi
Erika M Kwon
Janet L Stanford
Peter S Nelson
Sarah K Holt
P2860
P304
P356
10.1158/1078-0432.CCR-07-4566
P407
P577
2008-06-01T00:00:00Z